TIP24-199: Rhenium (Re-186) Obisbemeda {Re-186-Nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1-4

J Natl Compr Canc Netw. 2024 Apr 5;22(2.5):TIP24-199. doi: 10.6004/jnccn.2023.7222.NO ABSTRACTPMID:38580269 | DOI:10.6004/jnccn.2023.7222

Source: Journal of the National Comprehensive Cancer Network : JNCCN - April 5, 2024 Category: Cancer & Oncology Authors: Norman LaFrance Andrew Brenner Priya Kumthekar Michael Youssef Ande Bao Melissa Moore Joel Michalek Marc Hedrick William Phillips Toral Patel Jeffrey Weinberg John Floyd Source Type: research